Skip to main content
Home Beijing 2022 Winter Games
  • News
  • Galleries
  • Medals
  • Schedule
Copy link
Related Topics
Regeneron Pharmaceuticals Inc Eli Lilly and Co Indianapolis United States United States government Donald Trump Business 2019-2020 Coronavirus pandemic Diagnosis and treatment Health New product development New products and services Products and services Corporate news Coronavirus Infectious diseases Diseases and conditions Lung disease Stock price movements Stock performance Corporate stock Medication Earnings estimates Earnings Financial performance Pharmaceutical manufacturing Health care industry
More From
Photo Gallery
Lilly stays confident in possible COVID drug after setback
FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)

Oct. 27, 2020 08:38 AM EDT
Copy link
FILE - In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, Oct. 26, 2020, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help. (David Morrison/Eli Lilly via AP, File)

FILE - In this May 2020 file photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Monday, Oct. 26, 2020, U.S. government officials announced they are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to help. (David Morrison/Eli Lilly via AP, File)

Oct. 26, 2020 06:54 PM EDT
Copy link
Latest News

AP source: LeBron James inks 2-year extension with Lakers

By Greg Beacham 58 minutes ago

Today in Sports: Usain Bolt wins three gold medals.

By The Associated Press 7 hrs ago

Japan makes arrests on bribery suspicions in Tokyo Olympics

By Yuri Kageyama 10 hrs ago

Indian court appoints committee to run national Olympic body

14 hrs ago

Afghan Olympians resettle in Australia to start afresh

16 hrs ago
AP Sports | © 2022 Associated Press
  • Privacy Policy
  • Terms of Use
  • AP News
  • AP Images
  • ap.org